Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
ATAptarGroup, Inc. logo

AptarGroup, Inc. (ATR)

New York Stock Exchange · Currency in USD
$126.55 ▼ -1.55 (-1.21%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$128.10
Open
$126.90
Day's Range
$125.69 – $127.96
52 Week Range
$103.23 – $146.91
Volume
354,358
Avg. Volume
461,098
Market Cap
$8.05B
Beta (5Y Monthly)
0.34
PE Ratio (TTM)
22.60
EPS (TTM)
$5.68
Earnings Date
Oct 29, 2026
Forward Dividend & Yield
$1.92 (1.52%)
Ex-Dividend Date
Jul 30, 2026
1y Target Est
$148.33

Profile: AptarGroup, Inc.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
14,000
CEO
Gael Touya
Website
aptar.com

AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations.

Earnings

Next report: Thu, Oct 29, 2026
EPS estimate $1.47 · Revenue est. $980.76M
DateEst.Actual
Jul 30, 2026$1.35$1.42Beat
Apr 30, 2026$1.15$1.19Beat
Feb 5, 2026$1.24$1.25Beat
Oct 30, 2025$1.57$1.62Beat
Jul 31, 2025$1.58$1.66Beat
May 1, 2025$1.16$1.20Beat

Analyst view

Consensus price target
$148.33 ▲ +17.2%
Range $135.00 – $160.00
Rating: Buy
Buy 44% · Hold 39% · Sell 17%

Get free alerts on ATR and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.